This was confirmed by the upregulation of key genes involved in meso-endodermal differentiation and the downregulation of important pluripotency genes including NANOG. These findings highlight how deregulated BMP signalling in CML could lead to an altered balance between self-renewal and differentiation. The gene discussed is NANOG; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.